Conectados: Social Networks and Social Media for Vaccine Uptake
NCT07096245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 507
Last updated 2026-03-06
Summary
This study is testing different ways of sharing a short, community-informed video about flu and COVID-19 vaccines to see how people respond to it. The video was created with input from Indigenous community members in California and provides information to support vaccine decision-making. Participants may see the video in one of three ways: through a paid advertisement on social media, from a trusted community organization, or from someone they know personally. After watching the video, viewers will be asked to answer one question about how much they trust it, and they may choose to complete a short survey about their vaccine views and how they received the video. The goal is to understand how trust in vaccine information changes depending on who shares it, and to improve the way health messages are delivered to Indigenous and other underserved communities.
Conditions
- Vaccination
Interventions
- BEHAVIORAL
-
Vaccine Information Video Dissemination
The intervention is a brief, community-informed educational video (2-3 minutes) focused on seasonal flu and COVID-19 vaccination. The video was developed using human-centered design and community-based participatory methods with Indigenous community members in California. It aims to promote trust in vaccines by presenting clear, culturally relevant health information. The video is disseminated using three behavioral delivery strategies: (1) paid advertisements on Facebook and Instagram targeting adults in California, (2) peer-to-peer sharing by participants who previously enrolled in the study and are invited to serve as "seeds" who share the video with their personal contacts, and (3) distribution by trusted community-based organizations (CBOs) using their existing communication networks, including WhatsApp, social media, email, and newsletters. All viewers are prompted to complete a one-question trust poll and invited to participate in an optional anonymous survey on vaccine attitud
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Nadia Diamond-Smith, PhD, MS · University of California, San Francisco
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-10
- Primary Completion
- 2025-12-15
- Completion
- 2025-12-15
Countries
- United States
Study Locations
More Related Trials
-
Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders
NCT00153543 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults
NCT04651790 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4
NCT04559204 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
NCT01619462 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of PCV on Disease and Colonization Among Native American Communities
NCT01083459 ·Status: COMPLETED
-
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects
NCT00269672 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Persuasiveness of Pro-inoculation Arguments
NCT05804825 ·Status: COMPLETED ·Phase: NA
-
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
NCT04398706 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
NCT02955160 ·Status: COMPLETED ·Phase: PHASE1
-
Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.
NCT04583618 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults
NCT03549208 ·Status: UNKNOWN ·Phase: PHASE1
-
Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico
NCT00708682 ·Status: COMPLETED ·Phase: PHASE3
-
Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
NCT00999739 ·Status: UNKNOWN ·Phase: PHASE3
-
PRomoting Older Adults' Pneumococcal Vaccination Through Education and Learning
NCT06234683 ·Status: COMPLETED ·Phase: NA
-
Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine
NCT00152802 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population
NCT05135585 ·Status: COMPLETED ·Phase: NA
-
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants
NCT04382326 ·Status: COMPLETED ·Phase: PHASE3
-
Reduced PCV Dosing Schedules in South African Infants
NCT02943902 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
NCT00546572 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly
NCT02451969 ·Status: COMPLETED ·Phase: PHASE3
-
Pneumonia Vaccine Education Intervention Study
NCT06136832 ·Status: COMPLETED ·Phase: NA
-
Systems Biology of PNEUMOVAX®23 and PREVNAR 13®
NCT01307449 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae
NCT02116998 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.
NCT00368966 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
NCT06271681 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4